Skip to main content

Alterity Therapeutics Limited - American Depositary Shares (NQ:ATHE)

2.940 +0.020 (+0.68%)
Streaming Delayed Price Updated: 9:30 AM EST, Dec 18, 2025 Add to My Watchlist

Price and Volume

Detailed Quote
Volume 621
Open 2.940
Bid (Size) 2.930 (500)
Ask (Size) 3.150 (100)
Prev. Close 2.920
Today's Range 2.940 - 2.940
52wk Range 2.040 - 7.000
Shares Outstanding 2,084,016,678
Dividend Yield N/A

Performance

YTD
-21.2%
-21.2%
1 Month
-22.5%
-22.5%
3 Month
-34.2%
-34.2%
6 Month
-32.3%
-32.3%
1 Year
+29.5%
+29.5%

More News

Read More

Frequently Asked Questions

Is Alterity Therapeutics Limited - American Depositary Shares publicly traded?
Yes, Alterity Therapeutics Limited - American Depositary Shares is publicly traded.
What exchange does Alterity Therapeutics Limited - American Depositary Shares trade on?
Alterity Therapeutics Limited - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Alterity Therapeutics Limited - American Depositary Shares?
The ticker symbol for Alterity Therapeutics Limited - American Depositary Shares is ATHE on the Nasdaq Stock Market
What is the current price of Alterity Therapeutics Limited - American Depositary Shares?
The current price of Alterity Therapeutics Limited - American Depositary Shares is 2.940
When was Alterity Therapeutics Limited - American Depositary Shares last traded?
The last trade of Alterity Therapeutics Limited - American Depositary Shares was at 12/18/25 09:30 AM ET
What is the market capitalization of Alterity Therapeutics Limited - American Depositary Shares?
The market capitalization of Alterity Therapeutics Limited - American Depositary Shares is 6.13B
How many shares of Alterity Therapeutics Limited - American Depositary Shares are outstanding?
Alterity Therapeutics Limited - American Depositary Shares has 6B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.